CLSI Publishes Principles and Procedures for Blood Cultures, 2nd Edition
April 25, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of M47—Principles and Procedures for Blood Cultures.
Read MoreCLSI Press Releases
CLSI is your source for laboratory standards news and information.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
Biotech Executive, Barbara J. Jones, Ph.D., Named New CEO of the Clinical and Laboratory Standards Institute
April 12, 2022
Biotech executive, Barbara J. Jones, Ph.D., has been named Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI) effective May 16, 2022. The current CLSI CEO, Glen Fine, announced his retirement in January 2022 and is set to depart the organization after 17 years at the helm.
Read More
CLSI Publishes M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition
March 15, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition.
Read MoreCLSI Announces New Members of Board of Directors
February 17, 2022
CLSI announces the election of three new Board members. Serving as new Directors are Collette Fitzgerald, PhD, Tania Motschman, MS, MT(ASCP)SBB, and Susan Sharp, PhD, D(ABMM), F(AAM).
Read More
CLSI publishes new guideline M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data
February 7, 2022
The Clinical and Laboratory Standards Institute (CLSI) has published the 5th edition of M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. This guideline describes methods for recording and analyzing antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.
Read MoreCLSI 2022 Excellence Awards
January 19, 2022
The Clinical and Laboratory Standards Institute announces the recipients of its 2022 Excellence Awards. These awards celebrate the achievements of CLSI volunteers who have helped improve the quality of medical care worldwide.
Read More
CLSI Publishes New Guideline EP39—A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests
November 29, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of guideline EP39—A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests.
Read More
CLSI Publishes New Guideline H62—Validation of Assays Performed by Flow Cytometry
November 5, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of H62—Validation of Assays Performed by Flow Cytometry.
Read MoreClinical and Laboratory Standards Institute CEO to Retire
November 2, 2021
Glen Fine, the Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI), announced he’s retiring effective Spring 2022. For 17 years Fine has served as the head of the globally recognized standards development organization in the field of laboratory medicine.
Read More
CLSI Publishes New Guideline MM24—Molecular Methods for Genotyping and Strain Typing of Infectious Organisms
October 19, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of MM24—Molecular Methods for Genotyping and Strain Typing of Infectious Organisms.
Read More